Status:
WITHDRAWN
A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Allergic Conjunctivitis
Eligibility:
All Genders
6+ years
Phase:
PHASE2
Brief Summary
This study will evaluate the safety and efficacy of a new allergy medication
Detailed Description
Study withdrawn prior to determining study details
Eligibility Criteria
Inclusion
- Be at least 6 years of age, of any race, or either gender.
- Have a positive allergic history of ocular allergies and a positive skin test reaction to cat hair/dander, ragweed, tree and/or grass pollen within the past 24 months.
- Have a calculated best-corrected visual acuity of 0.6 logMar or better in each eye as measured using an ETDRS chart.
- Positive bilateral CAC reaction at Visit 1 \& 2.
Exclusion
- Have any known contraindications, allergies, or sensitivities to the use of any of the study medications, or their components.
- Any ocular condition that, in the opinion of the investigator, could affect the subject's safety or trial parameters
- Manifest signs or symptoms of clinically active allergic conjunctivitis in either eye at the baseline slit-lamp exam of any visit
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00375596
Last Update
February 20 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.